| Antibodies against denatured HLA class II molecules detected in luminex-single antigen assay PC Grenzi, R de Marco, RZR Silva, ÉF Campos, M Gerbase-DeLima Human Immunology 74 (10), 1300-1303, 2013 | 68 | 2013 |
| The Kazal-type inhibitors infestins 1 and 4 differ in specificity but are similar in three-dimensional structure ITN Campos, T Souza, RJS Torquato, R De Marco, AM Tanaka-Azevedo, ... Acta Crystallographica Section D: Biological Crystallography 68 (6), 695-702, 2012 | 33 | 2012 |
| Impact of combinations of donor and recipient ages and other factors on kidney graft outcomes M Gerbase-DeLima, R De Marco, F Monteiro, H Tedesco-Silva, ... Frontiers in Immunology 11, 954, 2020 | 17 | 2020 |
| HLA‐A homozygosis is associated with susceptibility to COVID‐19 R de Marco, TC Faria, KL Mine, M Cristelli, JO Medina‐Pestana, ... HLA, 2021 | 16 | 2021 |
| The first pacifastin elastase inhibitor characterized from a blood sucking animal R De Marco, DV Lovato, RJS Torquato, RO Clara, DS Buarque, ... Peptides 31 (7), 1280-1286, 2010 | 16 | 2010 |
| Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes CM Teixeira, H Tedesco Silva Junior, LAR Moura, HMS Proença, ... PLoS One 15 (1), e0227445, 2020 | 15 | 2020 |
| Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donor AN Ferreira, CR Felipe, M Cristelli, L Viana, J Mansur, M de Paula, ... Transplant International 32 (11), 1127-1143, 2019 | 15 | 2019 |
| Donor-specific HLA antibodies are associated with graft failure and delayed hematologic recovery after unrelated donor hematopoietic cell transplantation ACM Lima, J Getz, GB do Amaral, G Loth, VAM Funke, SK Nabhan, ... Transplantation and Cellular Therapy 29 (8), 493. e1-493. e10, 2023 | 9 | 2023 |
| The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation K Linhares, JB Taddeo, MP Cristelli, H Proença, KN Ficher, R de Marco, ... Plos one 16 (5), e0251384, 2021 | 9 | 2021 |
| Untreated donor-specific HLA antibodies are associated with graft failure and poor survival after haploidentical transplantation with post-transplantation cyclophosphamide in … ACM Lima, C Bonfim, J Getz, GB do Amaral, RR Petterle, G Loth, ... Transplantation and Cellular Therapy 28 (10), 698. e1-698. e11, 2022 | 8 | 2022 |
| Long-term efficacy and safety of everolimus versus mycophenolate in kidney transplant recipients receiving tacrolimus KN Ficher, Y Dreige, PRG Lins, AN Ferreira, JT de Rezende Freschi, ... Transplantation 106 (2), 381-390, 2022 | 7 | 2022 |
| Disparity in the access to kidney transplantation for sensitized patients in the state of Sao Paulo-Brazil M Perosa, GF Ferreira, LG Modelli, MP Medeiros, SR Neto, F Moreira, ... Transplant Immunology 68, 101441, 2021 | 6 | 2021 |
| Kidney allocation system for transplantation in Brazil SBS Martins, BA Ferreira, VAC Gonçalves, R De Marco, MG de Lima, ... Current Transplantation Reports 6, 209-213, 2019 | 3 | 2019 |
| 29-P Heating the serum at 56° C for one minute solves the problem of inhibitory factors in the luminex antibody detection assays R de Marco, A Goncalves-Primo, ÉF Campos, M Gerbase-DeLima Human Immunology 1 (72), S33, 2011 | 3 | 2011 |
| Validation of a Phage Display Method for Protease Inhibitor Selection Using SFTI and HiTI Synthetic Hybrid Peptides R de Marco, S S Azzolini, D V Lovato, R JS Torquato, R Amino, ... Combinatorial Chemistry & High Throughput Screening 13 (9), 829-835, 2010 | 3 | 2010 |
| A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial JT de Rezende Freschi, MP Cristelli, LA Viana, KN Ficher, MR Nakamura, ... Transplantation 108 (1), 261-275, 2024 | 2 | 2024 |
| The Problem and the Solution for Equitable Access of HLA-DR Homozygous Patients to Kidney Transplantation R de Marco, F Monteiro, LR Requião-Moura, J Medina-Pestana, ... Transplantation 107 (10), e269-e270, 2023 | 2 | 2023 |
| HLA‐DPB1 molecular mismatches are risk factors for acute rejection and low 5‐year graft function in first kidney transplants R de Marco, LR Requião‐Moura, TRF Raimundo, TB Mourão, ... HLA 101 (3), 228-238, 2023 | 1 | 2023 |
| High soluble HLA‐DQB2 levels in posttransplant serum are associated with kidney graft dysfunction KL Mine, R de Marco, TRF Raimundo, JV Ernesto, JO Medina‐Pestana, ... International Journal of Immunogenetics 49 (2), 63-69, 2022 | 1 | 2022 |
| 306.5: a prospective study of donor-specific anti-HLA antibody monitoring in pancreas transplantation M Perosa, AC Vidigal, F Danziere, R De Marco, D Malheiros, J Branez, ... Transplantation 105 (12S1), S20, 2021 | 1 | 2021 |
